AION Labs unveils TenAces startup, will use AI to predict molecular glue
The company aims to improve the success rate of the discovery of treatments for a range of conditions.
Stay updated with breaking news from Arnout Schepers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The company aims to improve the success rate of the discovery of treatments for a range of conditions.
AION Labs, an Israeli organization that is the first-of-its-kind venture studio “spearheading” the adoption of AI technologies and computational science to solve therapeutic challenges, formed the new venture TenAces Biosciences. TenAces is a startup developing what it describes as a novel approach to discovering new molecular glue therapies, leveraging machine learning to enhance the development […]
AION Labs, the first-of-its-kind venture studio spearheading the adoption of AI technologies and computational science to solve therapeutic…
TenAces will develop an AI platform to help identify protein interactions that naturally occur in the body to assist with targeted protein degradation.